CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

Dave Coulier’s new tongue cancer diagnosis raises questions about whether it’s linked to his prior lymphoma. Experts explain the risks, causes, and why second primary cancers can occur.

Dave Coulier revealed he is undergoing treatment for tongue cancer less than a year after beating non-Hodgkin lymphoma.

Dave Coulier recently revealed another cancer diagnosis, mere months after recovering from Stage 3 non-Hodgkin’s lymphoma ...

Dave Coulier announced he is undergoing treatment for tongue cancer nearly eight months after he beat his battle with ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced the commercial launch of ...

Full House' star Dave Coulier enters another cancer battle mere months after beating non-Hodgkin lymphoma. 'Totally unrelated ...

Comedian and actor Dave Coulier has announced he has been diagnosed with cancer for a second time. Coulier shared with the “ ...

Axi-cel demonstrated a 90% overall response rate and 75% complete response rate in relapsed/refractory indolent non-Hodgkin lymphoma. Median progression-free survival was 62.2 months, with a median ...

The drug is an IL-2 receptor-directed fusion protein designed to kill IL-2R–expressing cancer cells while depleting ...

(NEXSTAR) — Just months after sharing that he was cancer-free, “Full House” actor Dave Coulier says he has been diagnosed ...

Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio’s management teamHOUSTON, Dec.